Connie Kingry

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Medicine, Cardiology, Pharmacotherapy +17

Intravenous fenoldopam in heart failure: Comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside

James B. Young, Carlos A. León, Craig M. Pratt et al. · American Heart Journal · 1988 · 41 citations

Medicine, Cardiology, Pharmacology +15

Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Connie Kingry, Arnaud Bastien, Gillian L. Booth et al. · The American Journal of Cardiology · 2007 · 34 citations · Full text

Medicine, Chronic Disease Control, Chronic Disease Prevention +13

Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity

John J. Mahmarian, Frank W. Smart, Lemuel A. Moyé et al. · The American Journal of Cardiology · 1994 · 31 citations

Medicine, Cardiology, Pharmacology +14

Operational Aspects of Terminating the Doxazosin Arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Sara Pressel, Barry R. Davis, Jackson T. Wright et al. · Controlled Clinical Trials · 2001 · 20 citations

Medicine, Cardiology, Pharmacology +10